Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03846427
Title Study of Zanubrutinib (BGB-3111) in Patients With Marginal Zone Lymphoma
Acronym MAGNOLIA
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors BeiGene
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | NZL | ITA | GBR | FRA | CZE | AUS


No variant requirements are available.